Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IRAK1 anticorps (AA 301-400)

IRAK1 Reactivité: Humain, Rat ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1387749
  • Antigène Voir toutes IRAK1 Anticorps
    IRAK1 (Interleukin-1 Receptor-Associated Kinase 1 (IRAK1))
    Épitope
    • 32
    • 24
    • 17
    • 15
    • 11
    • 8
    • 8
    • 6
    • 6
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 301-400
    Reactivité
    • 150
    • 86
    • 62
    • 2
    • 1
    • 1
    Humain, Rat
    Hôte
    • 149
    • 13
    • 2
    Lapin
    Clonalité
    • 152
    • 12
    Polyclonal
    Conjugué
    • 61
    • 9
    • 8
    • 8
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp IRAK1 est non-conjugé
    Application
    • 116
    • 68
    • 64
    • 57
    • 51
    • 26
    • 18
    • 13
    • 12
    • 12
    • 7
    • 4
    • 2
    • 1
    ELISA, Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
     Réactivité croisée
    Humain, Rat
    Homologie
    Mouse,Dog,Cow,Pig,Chicken,Rabbit
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human IRAK1
    Isotype
    IgG
  • Indications d'application
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Validation #029809 (Western Blotting)
    'Independent Validation' signe
    by
    Alamo Laboratories Inc
    No.
    #029809
    Date
    03.09.2014
    Antigène
    Numéro du lot
    140120
    Application validée
    Western Blotting
    Contrôle positif
    PC3 cells
    Contrôle négative
    C6/36 cells (non-reactive species)
    Conclusion
    A band was observed in the positive control sample at the correct molecular weight, which was absent from the negative control sample. Additional bands were also observed in the positive control sample, which were absent from the negative control. These bands may represent alternative IRAK1 isoforms.
    'Independent Validation' signe
    Validation Images
    Protocole
    Anticorps primaire
    • Antigen: Interleukin-1 Receptor-Associated Kinase 1 (IRAK1)
    • Catalog number: ABIN1387749
    • Lot number: 140120
    • Antibody Dilution: 1:100
    Anticorps secondaire
    • Antigen: Goat Anti-Rabbit IgG (H + L)-HRP Conjugate
    • Lot number: L170-6515
    • Antibody Dilution: 1:10,000
    Full Protocol
    • 1. The cell extracts were heated at 95°C for 5 minutes in 1X SDS Sample Buffer containing 1% SDS and 1.25% β-mercaptoethanol.
    • 2. 15 μl of heated culture-media were loaded and resolved on 8-16% SDS-polyacrylamide gel.
    • 3. The Thermo Scientific - Spectra Multicolor Broad Range (Cat # 26634) were used as molecular mass markers.
    • 4. Proteins were then transferred onto PVDF membrane by wet transfer and protein transfer was confirmed with Ponceau-S staining.
    • 5. The PVDF membrane was incubated with 25 ml of blocking buffer [Tris Buffered Saline, pH 7.4 plus 0.1% TW20 (TBST)] containing 5% (W/V) BSA at room temperature for 1 hour.
    • 6. The membrane was rinsed with TBST once.
    • 7. The membrane was immersed with the protein side up in the primary antibody solution in TBST containing 5% (W/V) BSA and incubated for 24 hours at 4°C.
    • 8. The membrane was rinsed in TBST thrice for 5 minutes each.
    • 9. The membrane was incubated in the HRP-conjugated secondary antibody solution in TBST containing 5% (W/V) BSA and incubated for 1 hour at room temperature (~26°C) with gentle agitation.
    • 10. The membrane was rinsed thrice TBST thrice for 5 minutes each.
    • 11. The membrane was rinsed in TBS twice for 30 seconds each.
    • 12. Signals were detected with ECL-2 Substrate. The blot was scanned for 45 minutes.
    • 13. The membrane was rinsed three times TBST.
    • 14. Incubated in Acidic Glycine Stripping Buffer at room temperature with gentle agitation for 3 times, 10 minutes each.
    • 15. The membrane was washed in TBST 2 times for 10 minutes each.
    • 16. Repeated Steps 5-12 with the loading control antibody (for Anti-actin) and its matching secondary antibody.
    Notes
    - No experimental challenges noted.
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Antigène
    IRAK1 (Interleukin-1 Receptor-Associated Kinase 1 (IRAK1))
    Autre désignation
    IRAK1 (IRAK1 Produits)
    Synonymes
    anticorps IRAK1, anticorps IRAK, anticorps pelle, anticorps AA408924, anticorps IRAK-1, anticorps IRAK1-S, anticorps Il1rak, anticorps Plpk, anticorps mPLK, anticorps RGD1563841, anticorps interleukin 1 receptor associated kinase 1, anticorps interleukin-1 receptor-associated kinase 1, anticorps IRAK1, anticorps irak1, anticorps Irak1
    Sujet

    Synonyms: IRAK, pelle, Interleukin-1 receptor-associated kinase 1, IRAK-1, IRAK1

    Background: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.

    ID gène
    3654
    UniProt
    P51617
    Pathways
    Signalisation NF-kappaB, Signalisation TLR, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
Vous êtes ici:
Support technique